MDB Capital Holdings, LLC MDBH
- Market cap
- $26.9M
- P/E
- 0.0×
Follow MDBH
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | 7.35 | 5.78 | 3.11 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | — | — | — | — | 21.67 | 13.25 | 7.98 |
High Price
|
|||
| — | — | — | — | — | — | — | 40 | 16 | 14 |
Employees
|
|||
| — | — | — | — | — | — | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | — | — | — | 1 | 6 | 2 | 5 |
Revenue
|
|||
| — | — | — | — | — | — | 100.00% | 100.00% | 100.00% | 100.00% |
Gross Margin
|
|||
| — | — | — | — | — | — | (6) | (8) | 12 | (17) |
EBT
|
|||
| — | — | — | — | — | — | (481.96%) | (126.50%) | 557.39% | (345.61%) |
EBT Margin
|
|||
| — | — | — | — | — | — | (6) | (8) | 12 | (21) |
Net Income
|
|||
| — | — | — | — | — | — | 0 | (1) | 0 | 0 |
Depreciation
|
|||
| — | — | — | — | — | — | 0.19 | 0.74 | 0.23 | 0.49 |
Revenue/Sh
|
|||
| — | — | — | — | — | — | (0.90) | (1.04) | 1.31 | (2.14) |
Earnings/Sh
|
|||
| — | — | — | — | — | — | (1.01) | (0.88) | (0.96) | (0.57) |
Cash Flow/Sh
|
|||
| — | — | — | — | — | — | (0.03) | (0.05) | 0.06 | 0.00 |
Capex/Sh
|
|||
| — | — | — | — | — | — | (1.04) | (0.93) | (0.90) | (0.57) |
Free CF/Sh
|
|||
| — | — | — | — | — | — | 3.54 | 4.61 | 7.44 | 6.04 |
Book Value/Sh
|
|||
| — | — | — | — | — | — | 7 | 8 | 9 | 10 |
Shares
|
|||
| — | — | — | — | — | — | 0.00 | 0.00 | 4.81 | 0.00 |
PE Ratio
|
|||
| — | — | — | — | — | — | 16.07 | 15.86 | 27.52 | 6.63 |
PS Ratio
|
|||
| — | — | — | — | — | — | 3.87 | 2.55 | 0.85 | 0.54 |
PB Ratio
|
|||
| — | — | — | — | — | — | 12.15 | 9.73 | (4.03) | (5.21) |
EV/Sales
|
|||
| — | — | — | — | — | — | (9.09) | (7.71) | 1.02 | 5.10 |
EV/FCF
|
|||
| — | — | — | — | — | — | (7) | (7) | (9) | (6) |
Op' Cash Flow
|
|||
| — | — | — | — | — | — | 0 | 0 | 1 | 0 |
Capex
|
|||
| — | — | — | — | — | — | (7) | (8) | (8) | (6) |
FCF
|
|||
| — | — | — | — | — | — | 21 | 34 | 69 | 60 |
Working Cap'
|
|||
| — | — | — | — | — | — | — | — | — | — | Total Debt | |||
| — | — | — | — | — | — | (22) | (37) | (68) | (58) |
Net Debt
|
|||
| — | — | — | — | — | — | 23 | 37 | 70 | 61 |
Sh' Equity
|
|||
| — | — | — | — | — | — | 0.00% | (20.29%) | 20.34% | (31.31%) |
ROA
|
|||
| — | — | — | — | — | — | (431.00%) | (916.28%) | (888.56%) | (458.18%) |
ROIC
|
|||
| — | — | — | — | — | — | 0.00% | (23.06%) | 21.77% | (32.52%) |
ROE
|
|||
MDB Capital Holdings, LLC peers in Capital Markets
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| GRAN Grande Group Limited | $26.9M | — | Compare |
| ATCH AtlasClear Holdings, Inc. | $28.2M | 0.0× | Compare |
| FLD Fold Holdings, Inc. | $29.8M | 0.0× | Compare |
| DRK Sphere 3D Corp. | $32.2M | 0.0× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| COHN Institutional Financial Markets, Inc. | $32.6M | 1.0× | Compare |
| PLUT Plutus Financial Group Limited | $34.8M | — | Compare |
| BGDE Mawson Infrastructure Group Inc. | $35.4M | 0.0× | Compare |
| ARBK Argo Blockchain PLC Sponsored ADR | $35.6M | 0.0× | Compare |
MDB Capital Holdings, LLC (MDBH) key facts
- MDB Capital Holdings, LLC (MDBH) is a Capital Markets company in the Financial sector, listed on Nasdaq.
- As of September 25, 2026, MDBH traded at $2.46, a market capitalization of $26.9 million.
- Return on equity was −32.5% and debt-to-equity 0.00.
MDB Capital Holdings, LLC (MDBH) Latest News
17 Aug
MDB Capital Holdings LLC highlighted strategic pivots and asset adjustments during its Q2 2026 earnings call. Strategic pivots represent major moves that could significantly shift company trajectory and investor views.
14 Aug
MDB Capital Holdings, LLC Class A common held Q2 2026 earnings call covering financial results, operations and outlook. Earnings call results typically influence near-term sentiment and trading but rarely shift long-term company trajectory.
23 Jul
PatentVest Pulse from MDB Capital Holdings examines OpenAI's patent filings to identify specific technologies and strategies in its intellectual property holdings. MDBH's PatentVest tool gains visibility through OpenAI patent analysis that may boost service adoption and market positioning.
30 Jun
PatentVest released its new PatentVest Pulse Report examining strategic shifts beyond GLP-1 for MDB Capital Holdings, LLC (MDBH). Report release on strategic direction may moderately affect MDBH positioning and investor views but lacks immediate financial or operational details.
4 Jun
MDB Capital Holdings releases PatentVest Pulse Report mapping emerging muscle-preservation category that expands GLP-1 opportunity. Report maps new market expansion in GLP-1 sector for MDBH operations.
8 May
MDB Capital Holdings, LLC (MDBH) releases PatentVest Pulse Report mapping triple-agonist race and emerging patent battles shaping post-GLP-1 obesity market. Report positions MDBH as thought leader in patent analysis for high-growth obesity drug sector, boosting investor interest and strategic opportunities.
29 Apr
Retatrutide surpasses bariatric surgery weight loss thresholds, but intense competition in obesity drugs is just beginning. Retatrutide's milestone escalates obesity drug competition, moderately affecting MDBH's biotech investment positioning.
6 Apr
MDB Capital Holdings LLC (MDBH) showcased strategic innovations in Q4 2025 earnings call highlights, emphasizing key advancements and future growth initiatives. Strategic innovations in Q4 2025 earnings call represent major moves likely to alter MDBH's trajectory and investor sentiment.
1 Apr
MDB Capital Holdings, LLC released Q4 2025 Earnings Call Summary for Class A common stock, covering financial results, operations, and outlook. Q4 earnings call summary discloses key financial metrics, strategic updates, and guidance that significantly influence future performance and investor sentiment.
31 Mar
MDB Capital Holdings, LLC (MDBH) released its 2025 full-year update and shareholder letter. The 2025 full-year update and shareholder letter reveal strategic initiatives and financial outlook poised to significantly shape MDBH's trajectory and investor sentiment.
PatentVest released a new Pulse Report analyzing the $19 billion race among Amylin drugs transforming obesity treatment. Pulse Report on high-stakes obesity drug sector boosts MDBH's profile in patent investment opportunities.
30 Mar
PatentVest, operated by MDB Capital Holdings (MDBH), announces partnership with Life Seal Vascular, acquiring an equity stake in exchange for providing IP intelligence services. Equity stake in vascular medtech firm via core IP services strengthens MDBH's investment portfolio and validates its business model.
11 Mar
PatentVest announced a strategic intellectual property collaboration with Porosome Therapeutics to strengthen its platform for developing therapeutics targeting secretory disorders. Strategic IP collaboration bolsters MDBH's therapeutics platform and competitive edge in biotech patent investing.
26 Feb
PatentVest released a new report analyzing the competitive patent landscape for oral small-molecule GLP-1 drugs, highlighting key players and opportunities in the rapidly growing sector. Report on high-demand GLP-1 patents spotlights MDBH's core patent investment strategy, potentially boosting market sentiment without guaranteeing major shifts.
2 Feb
MDB Capital Holdings, LLC (MDBH) has announced changes in its Board of Directors, including the appointment of new members and the resignation of others. These transitions are part of the company's strategy to enhance governance and align with its growth objectives. The new board members bring diverse expertise that is expected to contribute positively to the company's future direction. Board transitions may influence governance and strategic direction, impacting overall performance.
14 Jan
PatentVest has released a report detailing the ongoing intellectual property battle that is shaping the burgeoning $1.8 trillion space economy. The report highlights key players and strategies in the sector, emphasizing the importance of patents in securing competitive advantages and fostering innovation. As the space industry continues to expand, the implications of these IP disputes could significantly influence market dynamics and investment opportunities. The report outlines significant strategic moves and competitive dynamics in the rapidly growing space economy, which could alter MDBH's market positioning.
11 Dec
Keiretsu Forum and MDB Capital Holdings, LLC (MDBH) concluded 2025 with impactful investor summits and announced an expanded summit series for 2026, aiming to enhance investor engagement and opportunities. The expanded summit series is expected to moderately influence MDBH's market positioning and investor relations.
20 Nov
MDB Capital Holdings, LLC (MDBH) provided an update for the third quarter of 2025, highlighting key financial metrics and operational developments. The company reported growth in revenue and strategic advancements in its portfolio, indicating a positive trajectory. MDBH emphasized its commitment to innovation and market expansion, positioning itself favorably within its industry. The update reflects ongoing efforts to enhance shareholder value and adapt to market demands. The reported growth and strategic advancements are likely to significantly impact the company's future performance and investor sentiment.
28 Oct
MDB Capital Holdings, LLC (MDBH) has released the latest PatentVest Pulse Report, which analyzes the competitive and intellectual property landscape of the $133 billion cardiac diagnostics market. The report highlights key players, emerging technologies, and trends that could shape the future of cardiac diagnostics, providing valuable insights for investors and stakeholders in the healthcare sector. The report's insights into the competitive landscape and emerging technologies in a significant market could influence MDBH's strategic positioning and investor sentiment.
6 Oct
MDB Capital Holdings, LLC (MDBH) is set to present at the LD Micro Main Event XIX, a prominent investor conference. The event will take place on December 5-7, 2023, in Los Angeles, California. MDBH aims to showcase its business model and growth strategies to potential investors and stakeholders during this significant gathering. Participation in a major investor conference can enhance visibility and attract potential investment opportunities.
MDB Capital Holdings, LLC (MDBH) has been recognized as the 2,000th company by LD Micro, highlighting its growth and significance in the market. This milestone reflects MDBH's commitment to innovation and its role in the financial landscape, particularly in supporting micro-cap companies. The celebration marks a notable achievement for both MDBH and LD Micro, emphasizing the importance of small-cap investments in the broader economy. Recognition as the 2,000th company by LD Micro may enhance MDBH's visibility and investor sentiment, but the overall impact on its long-term trajectory is expected to be limited.
24 Sep
MDB Capital Holdings, LLC (MDBH) has announced the appointment of Dr. Sarah Cork as Senior Patent Attorney at PatentVest, enhancing its leadership in life sciences intellectual property. Dr. Cork brings extensive experience in patent law and will focus on strengthening the firm's capabilities in managing and monetizing intellectual property assets in the life sciences sector. The addition of a senior patent attorney may moderately enhance MDBH's competitive positioning in the life sciences sector.
27 Aug
MDB Capital Holdings, LLC (MDBH) has released its update for the second quarter of 2025, highlighting key financial metrics and operational developments. The report indicates growth in revenue and strategic initiatives aimed at enhancing market position. MDBH continues to focus on innovation and expanding its portfolio, which is expected to drive future performance. The company remains optimistic about its trajectory in the coming quarters. The update reveals significant growth and strategic initiatives that could alter the company's trajectory and investor sentiment.
IPO Angels has launched in a strategic partnership with MDB Capital Holdings, LLC (MDBH) to transform early-stage investing. This collaboration aims to leverage MDBH's expertise in capital markets and IPO processes to enhance investment opportunities for startups and investors alike. The initiative is expected to provide a more structured approach to early-stage funding, potentially benefiting both entrepreneurs and investors seeking innovative ventures. The partnership is likely to significantly impact MDBH's strategic positioning and investor sentiment in the early-stage investment landscape.
PatentVest and Docana have formed a strategic partnership aimed at enhancing intellectual property strategies and fostering innovation in artificial intelligence. This collaboration is expected to leverage both companies' strengths to accelerate the development and commercialization of AI technologies, ultimately benefiting their clients and stakeholders. The partnership is likely to significantly enhance MDBH's competitive positioning in the AI and IP sectors.
19 Aug
PatentVest has released its inaugural rankings for quantum computing, highlighting key players and innovations in the sector. The rankings aim to provide insights into the competitive landscape of quantum technology, showcasing companies that are leading in patent filings and technological advancements. MDB Capital Holdings, LLC (MDBH) is noted for its involvement in this emerging field, potentially influencing its market position and investment strategies. The release of quantum computing rankings could significantly impact MDBH's strategic positioning and investor sentiment in a rapidly evolving market.
24 Jul
Teragonia has established an Advisory Board aimed at accelerating its strategic growth initiatives. The board is composed of industry experts who will provide guidance and support to enhance Teragonia's market position and operational effectiveness. This move is expected to facilitate the company's expansion and innovation efforts. The formation of an Advisory Board indicates a significant strategic move that could enhance Teragonia's growth and market positioning.
10 Jul
MDB Capital Holdings, LLC (MDBH) has released the latest PatentVest Pulse Report, which analyzes the competitive and intellectual property landscape of the $188 billion surgical robotics market. The report highlights key players, emerging technologies, and trends shaping the industry, providing valuable insights for stakeholders and investors. It aims to assist companies in navigating the complex patent environment and making informed strategic decisions. The report's insights into the competitive landscape and emerging technologies in the surgical robotics market could significantly influence MDBH's strategic positioning and investor sentiment.
2 Jun
MDB Capital Holdings, LLC announced changes in its Board of Directors, highlighting new appointments and transitions aimed at enhancing governance and strategic direction. These changes are part of the company's ongoing efforts to align its leadership with its growth objectives and market demands. Board transitions can moderately influence the company's strategic direction and governance, impacting future performance.
27 May
ClearSign Technologies Corporation has announced changes to its Board of Directors, including the appointment of new members and the resignation of others. These changes are part of the company's strategy to enhance governance and drive future growth. The new board members bring diverse expertise and experience, which is expected to benefit the company's direction and operations. Board changes may influence governance and strategic direction, impacting overall company performance.